Dr. Ernesto Schiffrin has been awarded the American Heart Association’s 2011 Excellence Award for Hypertension Research, sponsored by Novartis. This is the most prestigious award conferred by the Council for High Blood Pressure Research, and recognizes researchers who have had a major impact in the field of hypertension and whose research has contributed to improved treatment and greater understanding of high blood pressure. The award was presented at the Council’s Scientific Sessions in Orlando, Florida in September.
Dr. Schiffrin is internationally recognized for his contributions as researcher, clinician, and educator in the field of hypertension. He serves multiple capacities at the Jewish General Hospital, as Physician-in-Chief and Director of the Cardiovascular Prevention Centre, Canada Research Chair in Hypertension and Vascular Research at the Lady Davis Institute, and Professor and Vice-Chair (Research) in the Department of Medicine at McGill University.
His research focuses on the mechanisms and treatment of high blood pressure. He investigates the biology of blood vessels and the roles of endothelin, angiotensin, nuclear receptors, inflammation and T cells in hypertension and the cardio-metabolic syndrome, the effects of anti-hypertensive treatment on the blood vessels of patients suffering from hypertension, and the molecular and cellular determinants of elevated blood pressure. He is the author of more than 450 peer-reviewed publications in the field, along with many book chapters, and is the editor of two books on the molecular and clinical aspects of vascular disease and hypertension.
To consult the original article on the Lady Davis site, click here